Stem Cell Therapy International Inc

Development of stem cell transplantation therapies and stem cell products

Calvin Cao, Chairman and CEO
Daniel J. Sullivan, CFO
Lixian (John) Jiang, COO

Yuriv V. Gladkikh, MD, Ph.D.
Galina Lobyntseva, BD, Ph.D.
Weiwen Deng, MD, Ph.D.
Alexey Bersenev, MD., Ph.D
Igor Katkov, Ph.D.
Nicholas Kipshidze, MD
Nikita Tregubov, MD.
Sean C. Orr, MD.
Salvador Vargas, MD.
Luis Jorge Quintero, MD.

2203 North Lois Ave.
9th Floor
Tampa, FL 33607
USA
Phone: +1-813-600-4088
Fax: +1-813-830-6112

Stem Cell Therapy International Inc. (SCTI) focuses on the development of stem cell transplantation therapy and stem cell products for the treatment of several human degenerative disorders such as diabetes, different fields of cancer, Down’s syndrome, diseases and disorders of the nervous system etc., as well as the ways of isolation of specific cells and their preservation.

The company’s strategies include the replacement and stimulation of influences on functionally defective cells and tissues in separate organs and systems, stimulation of the reparative and metabolic processes, immunological correction and stimulation.

The company has filed several patents. For more information, please refer to
the company’s website or the espacenet databases.